Sunshine Biopharma Inc.
SBFM· Nasdaq
SBFMSunshine Biopharma Inc.
Filed Mar 25, 2016 · 10-K · 85 days after period end · 0001354488-16-006700
derived · Computed from the longer spans the company filed.
| Metric | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures | Q4 2013dderived from reported figures | Q4 2012dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | — | $0.00 |
| Net Income | -$638.21K | -$386.59K | -$683.29K | -$188.76K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sunshine Biopharma Inc. · CIK 1402328 · Engraved from SEC EDGAR
ended Dec 31, 2015 · filed Mar 25, 2016 · 85 d after period end
